These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24528689)

  • 1. Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults.
    Kilgore M; Muntner P; Woolley JM; Sharma P; Bittner V; Rosenson RS
    J Clin Lipidol; 2014; 8(1):86-93. PubMed ID: 24528689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B).
    Elshazly MB; Quispe R; Michos ED; Sniderman AD; Toth PP; Banach M; Kulkarni KR; Coresh J; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2015 Aug; 132(8):667-76. PubMed ID: 26137953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in lipids and lipoproteins in US adults, 1988-2010.
    Carroll MD; Kit BK; Lacher DA; Shero ST; Mussolino ME
    JAMA; 2012 Oct; 308(15):1545-54. PubMed ID: 23073951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
    Hyre AD; Muntner P; Menke A; Raggi P; He J
    Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance between lipid markers used for predicting cardiovascular risk in patients with type 2 diabetes.
    Modi KD; Chandwani R; Ahmed I; Kumar KV
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S99-S102. PubMed ID: 26589777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.
    Mann D; Reynolds K; Smith D; Muntner P
    Ann Pharmacother; 2008 Sep; 42(9):1208-15. PubMed ID: 18648016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.
    Cobain MR; Pencina MJ; D'Agostino RB; Vasan RS
    Am J Med; 2007 Jul; 120(7):623-30. PubMed ID: 17602937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and control of dyslipidemia among persons with diabetes in the United States.
    Jacobs MJ; Kleisli T; Pio JR; Malik S; L'Italien GJ; Chen RS; Wong ND
    Diabetes Res Clin Pract; 2005 Dec; 70(3):263-9. PubMed ID: 15890427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.
    Hickman TB; Briefel RR; Carroll MD; Rifkind BM; Cleeman JI; Maurer KR; Johnson CL
    Prev Med; 1998; 27(6):879-90. PubMed ID: 9922071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.